Y
Yun Su
Researcher at Nanjing University of Chinese Medicine
Publications - 7
Citations - 1455
Yun Su is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 7, co-authored 7 publications receiving 1311 citations. Previous affiliations of Yun Su include Southeast University & Nanjing University.
Papers
More filters
Journal ArticleDOI
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Feng Jiang,Qi Qiu,Abha Khanna,Nevins W. Todd,Janaki Deepak,Lingxiao Xing,Huijun Wang,Zhenqiu Liu,Yun Su,Sanford A. Stass,Ruth L. Katz +10 more
TL;DR: Immunohistochemical analysis of 303 clinical specimens from three independent cohorts of lung cancer patients and controls show that expression of ALDH1 is positively correlated with the stage and grade of lung tumors and related to a poor prognosis for the patients with early-stage lung cancer.
Journal ArticleDOI
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.
TL;DR: Investigating the stem-cell-related function and clinical significance of the ALDH1A1 in human PCa found it to be a prostate CSC-related marker and measuring its expression might provide a potential approach to study tumorigenesis of PCa and predict outcome of the disease.
Journal ArticleDOI
Aldehyde Dehydrogenase 1 A1–Positive Cell Population Is Enriched in Tumor-Initiating Cells and Associated with Progression of Bladder Cancer
Yun Su,Qi Qiu,Xingqiao Zhang,Zhengran Jiang,Qixin Leng,Zhenqiu Liu,Sanford A. Stass,Feng Jiang +7 more
TL;DR: ALDH1A1 may serve as a useful marker for monitoring the progression of bladder tumor and identifying bladder cancer patients with poor prognosis who might benefit from adjuvant and effective treatments.
Journal ArticleDOI
Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection
Yun Su,Hong-Bin Fang,Feng Jiang +2 more
TL;DR: The integration of two different classes of biomarkers synergistically improves both the sensitivity and the specificity for the early detection of NSCLC.
Journal ArticleDOI
Small non-coding RNA biomarkers in sputum for lung cancer diagnosis
TL;DR: Combined analysis of the miRNAs and snoRNAs has a synergistic effect with 89 % sensitivity and 89-% specificity, and may provide a useful tool for lung cancer early detection.